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Inhibitor Relative 
conversion in 
presence of 
inhibitor
Relative reduction 
compared to no 
inhibitor
None 100% 0%
3 74.9 ± 0.4% 25.1%
4 91.6 ± 2.0% 8.4%
5 74.1 ± 7.2% 25.9%
6 92.0 ± 8.6% 8.0%
7 88.8 ± 4.0 % 11.2%
8 16.8 ± 1.8% 83.2%
9 <5% >95%
10 88.2 ± 5.4% 11.8%
11 <5% >95%
Introduction
Branched-chain fatty acids are common in the diet and are found in
medicines such as Ibuprofen and related drugs. Metabolism of branched-
chain fatty acids requires that the centres bearing the methyl groups
possess S-stereochemical configuration, but centres with R-configuration
are produced in the body and are found in the diet. Similarly, Ibuprofen and
related drugs require S-configuration for anti-inflammatory activity, but these
drugs are often given as a mixture of isomers. The enzyme α-methylacyl-
CoA racemase (AMACR) catalyses R- to S- conversion of 2-methylacyl-CoA
derivatives of fatty acids, enabling β-oxidation. Similarly, acyl-CoA
derivatives of Ibuprofen and similar drugs undergo R- to S- conversion,
resulting in pharmacological activation.1,2
AMACR levels are increased in all prostate cancers, some colon cancers
and other cancers.1-3 In prostate cancer, higher AMACR levels results in
higher rates of proliferation4 and androgen-independent growth5 and the
enzyme is recognised as a novel drug target. However, few inhibitors have
been identified, largely due to the difficulties in measuring enzyme activity
which makes it difficult to quantify drug potency.1 Recently, we showed that
AMACR is able to catalyse the irreversible elimination of hydrogen fluoride
from 3-fluoro-2-methyldecanoyl-CoA6 (Scheme 1).
Scheme 1: The AMACR catalysed elimination reaction.
This new reaction allows easier measurement of AMACR activity by 1H NMR
since the signals for the substrate and product 2-methyl groups appear in
different places in the spectrum.6 The reaction can potentially be adapted for
colorimetric or fluorescent measurement of AMACR activity by the use of
chromogenic substrates or fluoride sensors. This study3 focuses on using
the elimination reaction to measure drug potency and investigates
development of a colorimetric or fluorometric assay.
Results and Discussion
Recombinant human AMACR 1A was pre-incubated with a number of known
AMACR substrates or inhibitors before addition of 3-fluoro-2-
methyldecanoyl-CoA substrate 1 at 100 µM final concentration. After 1 hour
incubation at 30°C the reaction was terminated by heating and conversion
of 1 determined by 1H NMR. All known substrates and inhibitors reduced
conversion of 1 compared to positive controls (Table 1).3
Table 1: Inhibition of AMACR activity by known substrates and inhibitors.
Results are normalised to conversion levels in positive controls in order to
enable ranking of inhibitors. Values are means (n = 2)±SD.
The presence of known substrates 3-7 in the assay all resulted in modest
reductions in conversion of 1, due to competitive inhibition. In contrast,
inhibitor 8 almost completely abolished conversion of 1, consistent with it
been a known potent inhibitor (Figure 1). Protein modifying reagents 9-11
also reduced activity, in some cases abolishing enzyme activity.3
Figure 1: Reduction in conversion of 1 to 2 by the presence of 8, as
measuring the 2-Me group signal. A. No inhibitor; B. With 100 µM 8.
Synthesis of potential colorimetric substrates with aromatic side-chains was
performed.3 The acyl-CoA substrate 12 was converted to the expected
unsaturated product 13 by AMACR (Figure 2), but the resulting
chromophore had a maximum wavelength of <340 nm. Conversion of the
precursor acid to the acyl-CoA substrate was also difficult due to non-
enzymatic elimination of the fluoride, and hence this approach was
abandoned.
Figure 2: Conversion of aromatic substrate 12 to eliminated product 13.
A. Live enzyme; B. Negative control containing heat-inactivated enzyme.
Measurement of AMACR activity using fluoride sensors (Figure 3) was also
investigated.3 Several sensors were chosen due to their apparent
sensitivity and compatibility with aqueous environments. However, use of
these sensors to measure AMACR activity proved to be technically difficult.
Sensor 147 spontaneously decomposed in aqueous solution, generating a
fluorescent signal in the absence of fluoride. Sensors 158 and 169 gave a
better responses, but gave variable signal at the required fluoride
concentrations in aqueous solution. Sensor 1710 gave no fluorescent signal
in the presence of fluoride, whilst sensor 18 could not be synthesised by
literature methods.11
Figure 3: Fluoride sensors investigated to measure AMACR activity.
Conclusions
Conversion of 3-fluoro-2-methylacyl-CoA substrates by AMACR is reduced
in the presence of inhibitors. However the stability of colorimetric substrates
limits their use in AMACR activity assays. The investigated fluoride sensors
lacked sufficient reproducibility and sensitivity for use in an assay.
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